Effects of Citalopram on Cognitive Performance in Passive Avoidance, Elevated Plus-Maze and Three-Panel Runway Tasks in Naïve Rats

10.4077/CJP.2011.AMK077

Oguz Mutlu；Guner Ulak；Ipek Komsuoglu Çelikyurt；Firuzan Yildiz Akar；Faruk Erden

citalopram ； learning-memory ； elevated plus-maze ； passive avoidance ； three panel runway

The Chinese Journal of Physiology

54卷1期（2011 / 02 / 01）

36 - 46

英文

Recent studies have shown that learning and memory capacity is disturbed in depressive patients, and it is important to reveal the effects of antidepressant drugs on cognitive function in depressive patients with memory problems. Citalopram, a selective serotonin reuptake inhibitor (SSRI), is one of the most widely used drugs for the treatment of disorders related to serotonergic dysfunction like depression and anxiety. Contradictory findings exist regarding the effects of SSRIs on memory. The aim of this study is to investigate whether citalopram affects memory in various models of learning and memory tasks in rats. Citalopram (at 20 and 50 mg/kg) significantly shortened the retention latency in the passive avoidance test and prolonged the transfer latency on the second day at 10 and 50 mg/kg doses in the elevated plus-maze test. Citalopram also significantly increased the number of errors (at the 10 mg/kg dose) and prolonged the latency values compared to the control group in both reference and working memory trials in the three-panel runway test. Citalopram also impaired reference memory trials of animals at the 20 mg/kg dose. In conclusion, citalopram impaired cognitive performance in passive avoidance, elevated plus-maze and three-panel runway tasks in naïve rats. These effects might be related to serotonergic and nitrergic mechanisms, which need to be investigated in further studies.

1. Almeida, S.,Glahn, D.C.,Argyropoulos, S.V.,Frangou, S.(2009).Acute citalopram administration may disrupt contextual information processing in healthy males.Eur. Psychiat.,25,87-91.
2. Al-Zahrani, S.S.A.,Ho, M.Y.,Velazquez Martinez, D.N.,Cabrera, M.L.,Bradshaw, C.M.,Szabadi, E.(1996).Effect of destruction of the5-hydroxytryptaminergic pathways on the acquisition of temporal discrimination and memory for duration in a delayed conditional discrimination task.Psychopharmacology,123,103-110.
3. Archer, T.,Ogren, S.O.,Johansson, G.,Ross, S.B.(1984).The effect of acute zimeldine and alaproclate administration on the acquisition of two-way active avoidance: comparison with other antidepressant agents, test of selectivity and sub-chronic studies.Psychopharmacology,84,188-195.
4. Arenas, M.C.,Vinader-Caerols, C.,Monléon, S.,Martos, A.J.,Everss, E.,Ferrer-Ãńo, A.,Parra, A.(2006).Are the effects of the antidepressants amitriptyline, maprotiline, and fluoxetine on inhibitory avoidance state-dependent?.Behav. Brain. Res.,166,150-158.
5. Botzer, D.,Markovich, S.,Susswein, A.J.(1998).Multiple memory processes following training that a food is inedible in aplysia.Learn. Mem.,5,204-219.
6. Burghardt, N.S.,Sullivan, G.M.,McEwen, B.S.,Gorman, J.M.,LeDoux, J.E.(2004).The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine.Biol. Psychiatry,55,1171-1178.
7. Castellano, C.,Cestari, V.,Ciamei, A.(2001).NMDA receptors and learning and memory processes.Curr. Drug Targets,2,273-283.
8. Cremers, T.I.F.H.,Rea, K.,Bosker, F.J.,Wikström, H.V.,Hogg, S.,Mark, A.,Westerink, B.H.C.(2007).Augmentation of SSRI effects on serotonin by 5-HT2C antagonists: mechanistic studies.Neuropsychopharmacology,32,1550-1557.
9. De Oliveira, R.M.W.,Guimarães, F.S.,Deakin, J.F.W.(2008).Expression of neuronal nitric oxide synthase in the hippocampal formation in affective disorders.Braz. J. Med. Biol. Res.,41,333-341.
10. Egashira, N.,Matsumoto, Y.,Mishima, K.,Iwasaki, K.,Fujioka, M.,Matsushita, M.,Shoyama, Y.,Nishimura, R.,Fujiwara, M.(2006).Low dose citalopram reverses memory impairment and electroconvulsive shock-induced immobilization.Pharmacol. Biochem. Behav.,83,161-167.
11. Everitt, B.J.,Robbins, T.W.(1997).Central cholinergic systems and cognition.Annu. Revi. Psychol.,48,649-684.
12. Finkel, M.S.,Laghrissi-Thode, F.,Pollock, B.G.,Rong, J.(1996).Paroxetine is a novel nitric oxide synthase inhibitor.Psychopharmacol. Bull.,32,653-658.
13. Fuller, R.W.(1995).Serotonin uptake inhibitors: uses in clinical therapy and in laboratory research.Prog. Drug Res.,45,167-204.
14. Haider, S.,Shameem, S.,Ahmed, S.P.,Perveen, T.,Halem, D.J.(2005).Repeated administration of lead decreases brain 5-HT metabolism and produces memory deficits in rats.Cell. Mol. Biol. Lett.,10,669-676.
15. Harmer, C.J.,Bhagwagar, Z.,Cowen, P.J.,Goodwin, G.M.(2002).Acute administration of citalopram facilitates memory consolidation in healthy volunteers.Psychopharmacology (Berl),163,106- 110.
16. Hashimoto, S.,Inoue, T.,Muraki, I.,Koyama, T.(2009).Effects of acute citalopram on the expression of conditioned freezing in naive versus chronic citalopram-treated rats.Prog. Neuropsychopharmacol. Biol. Psych.,33,113-117.
17. Hjorth, S.,Westlin, D.,Bengtsson, H.J.(1997).WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto) receptor blocker versus that of the 5-HT reuptake inhibitor.Neuropharmacology,36,461-465.
18. Hlinak, Z.,Krejci, I.(2002).MK-801 induced amnesia for the elevated plus-maze in mice.Behav. Brain. Res.,131,221-225.
19. Holland, P.C.,Bouton, M.E.(1999).Hippocampus and context in classical conditioning.Curr. Opin. Neurobiol.,9,195-202.
20. Kandel, E.R. (ed.),Schwartz, J.H. (ed.),Jessel, T.M. (ed.)(2000).Principles of neural science.McGraw-Hill.
21. Kizilbash, A.H.,Vanderploeg, R.D.,Curtiss, G.(2002).The effects of depression and anxiety on memory performance.Arch. Clin. Neuropsychol.,17,57-67.
22. Kruglikov, R.I.,Uniyal, M.,Getsova, V.M.(1976).Relationship between the peculiarities of elaboration and retention of brightness discrimination and the serotonin content in the rat brain.Acta Neurobiol. Exp.,36,417-425.
23. Levey, A.I.(1996).Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.Proc. Natl. Acad. Sci.,93,13541-13546.
24. Li, Y.F.,Zhang, Y.Z.,Liu, Y.Q.,Wang, H.L.,Cao, J.B.,Guan, T.T.,Luo, Z.P.(2006).Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants.J. Psychopharmacol.,20,629-635.
25. Majlessi, N.,Nagndi, N.(2002).Impaired spatial learning in the morris water maze induced by serotonin reuptake inhibitors in rats.Behav. Pharmacol.,13,237-242.
26. Malberg, J.E.,Eisch, A.J.,Nestler, E.J.,Duman, R.S.(2000).Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.J. Neurosci.,20,9104-9110.
27. Manev, H.,Uz, T.,Smalheiser, N.R.,Manev, R.(2001).Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro.Eur. J. Pharmacol.,411,67-70.
28. Masand, P.S.,Gupta, S.(1999).Selective serotonin-reuptake inhibitors: an update.Harv. Rev. Psychiatry,7,69-84.
29. Meneses, A.(1999).5-HT system and cognition.Neurosci. Biobehav. Rev.,23,1111-1125.
30. Monleón, S.,Casino, A.,Vinader-Caerols, C.,Arenas, M.C.(2001).Acute effects of fluoxetine on inhibitory avoidance cosolidation in male and female OF1 mice.Neurosci. Res. Communn.,28,123- 130.
31. Monleón, S.,Urquiza, A.,Arenas, M.C.,Vinader-Caerols, C.,Parra, A.(2002).Chronic administration of fluoxetine impairs inhibitory avoidance in male but not female mice.Behav. Brain. Res.,136,483-488.
32. Monleón, S.,Vinader-Caerols, C.,Arenas, M.C.,Parra, A.(2008).Antidepressant drugs and memory: Insights from animal studies.Eur. Neuropsychopharmacol.,18,235-248.
33. Naghdi, N.,Majlessi, N.(2000).Effects of citalopram on learning and memory in the mouse and rat.Iran Biomed. J,4,21-29.
34. Nakazato, E.,Yamamoto, T.,Ohno, M.,Watanabe, S.(2000).Cholinergic and glutamatergic activation reverses working memory failure by hippocampal histamin H1 receptor blockade in rats.Life Sci.,67,1139-1147.
35. Nyth, A.L.,Gottfries, C.G.(1990).The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders.Br. J. Psychiatry,157,894-901.
36. Nyth, A.L.,Gottfries, C.G.,Lyby, K.,Smedegaard-Andersen, L.,Gylding-Sabroe, J.,Kristensen, M.,Refsum, H.E.,Öfsti, E.,Eriksson, S.,Syversen, S.(1992).A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia.Acta Psychiatr. Scand.,86,138- 145.
37. Ogren, S.O.,Stone, W.S.,Altman, H.J.(1985).Evidence for a functional interaction between serotonergic and cholinergic mechanisms in memory retrieval.Soc. Neurosci. Abstr.,256,11.
38. Ohno, M.,Yamamoto, T.,Ueki, S.(1991).Effect of the K-receptor agonist, U-50,488,H, on cerebral ischemia-induced impairment of working memory assessed in rats by a three-panel runway task.Eur. J. Pharmacol.,193,357-361.
39. Ohno, M.,Yamamoto, T.,Watanabe, S.(1992).Effects of intrahippocampal injections of n-methyl-d-aspartate receptor antagonists and scopolamine on working and reference memory assessed in rats by a three-panel runway task.J. Pharmacol. Exp. Ther.,263,943.
40. Olton, D.S.,Becker, J.T.,Handelmann, G.E.(1979).Hippocampus, space, and memory.Behav. Brain Sci.,2,313-365.
41. Phillips, R.G.,LeDoux, J.E.(1995).Lesions of the fornix but not the entorhinal or perirhinal cortex interfere with contextual fear conditioning.J. Neurosci.,15,5308-5315.
42. Pollock, B.G.,Mulsant, B.H.,Rosen, J.,Sweet, R.A.,Mazumdar, S.,Bharucha, A.,Marin, R.,Jacob, N.J.,Huber, K.A.,Kastango, K.B.,Chew, M.L.(2002).Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients.Am. J. Psychiatry,159,460-465.
43. Prickaerts, J.,Steinbusch, H.W.M.,Smits, J.F.M.,De Vente, J.(1997).Possible role of nitric oxide-cyclic GMP pathway in object recognition memory: effects of 7-nitroindazole and zaprinast.Eur. J. Pharmacol.,337,125-136.
44. Reddy, D.S.,Kulkarni, S.K.(1998).Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging- and dizocilpine-induced learning impairment.Brain Res.,799,215- 229.
45. Riekkinen, P.J.R.,Jaäkaälä, P.,Sirvio, J.,Riekkinen, P.(1991).The effects of increased serotonergic and decreased cholinergic activities on spatial navigation performance in rats.Pharmacol. Biochem. Behav.,39,25-29.
46. Sharma, A.C.,Kulkarni, S.K.(1992).Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice.Prog. Neuro-Psychopharmacol. Biol. Psychiatry,16,117- 125.
47. Shimizu-Sasamata, M.,Yamamoto, M.,Harada, M.(1993).Cerebral activating properties of indeloxazine HCl and its optical isomers.Pharmacol. Biochem. Behav.,45,335-341.
48. Stahl, S.M.(1998).Basic psychopharmacology of antidepressants. part 1: antidepressants have seven distinct mechanism of action.J. Clin. Psychiatry,59,5-14.
49. Tohgi, H.,Abe, T.,Nakanishi, S.,Furuichi, H.,Takahashi, S.,Mtatsumura, T.,Kurimoto, T.(1995).Effects of citalopram, a synthetic serotonin uptake inhibitor, on indoleamine and catecholamine concentrations in the cerebrospinal fluid of freely moving rats.J. Neural. Transm. Park Dis. Dement. Sect.,9,111-119.
50. Ulak, G.,Mutlu, O.,Akar, F.Y.,Komsuoǧlu, F.I.,Tanyeri, P.,Erden, B.F.(2008).Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)- imidazole augment the effects of antidepressants acting via serotonergic system in the forced swimming test in rats.Pharm. Biochem. Behav.,90,563-568.
51. Vanderwolf, C.H.(1987).Near total loss of "learning" and "memory" as a result of combined cholinergic and serotonergic blockade in the rat.Behav. Brain. Res.,23,43-57.
52. Wakely, S.W (ed.)(1998).Physiology of behavior.Needham Heights, MA:Allyn and Bacon.
53. Wegener, G.,Volke, V.,Harvey, B.H.,Rosenberg, R.(2003).Local, but not systemic administration of serotonergic antidepressants decreases hippocampal nitric oxide synthase activity.Brain Res.,959,128-134.
54. Wetzel, W.,Getsova, V.M.,Jork, R.,Matthies, H.(1980).Effect of serotonin on Y-maze retention and hippocampal protein synthesis in rats.Pharmacol. Biochem. Behav.,12,319-322.
55. Yamaguchi, T.,Suzuki, M.,Yamamoto, M.(1997).Facilitation of acetylcholine release in rat frontal cortex by indeloxazine hydrochloride: involvement of endogenous serotonin and 5-HT4 receptors.Naunyn-Schmiedeberg's Arch. Pharmacol.,356,712- 720.
56. Zarrindast, M.R.,Ghiasvand, M.,Homayoun, H.,Rostami, P.,Shafaghi, B.,Khavandgar, S.(2003).Adrenoceptor mechanisms underlying imipramine-induced memory deficits in rats.J. Psychopharmacol.,17,83-88.
57. Zobel, A.W.,Schulze-Rauschenbach, S.,vonWiddern, O.C.,Metten, M.,Freymann, N.,Grasmader, K.,Pfeiffer, U.,Schnell, S.,Wagner, M.,Maier, W.(2004).Improvement of working but not declarative memory is correlated with HPA normalization during antidepressant treatment.J. Psychiatr. Res.,38,377-383.

1. Sheikhi, Mehdi,Shafiee, Mahsa,Nassiri-Asl, Marjan,Abbasi, Esmail(2013).Effects of Vitexin on Scopolamine-Induced Memory Impairment in Rats.中國生理學雜誌,56(3),184-189.